Investigational New Drug (IND) application is a big milestone in the lengthy new drug development process, and innovators are looking for a fast and cost-effective approach to bringing their new drugs from late discovery to IND submission from CDMO partners. We offer an integrated pre-formulation service for our late discovery phase and early development stage customers – “IEPP: IND Enabling Pre-formulation Package” to provide a fast and optimal preformulation and drug delivery technology assessment including animal PK studies to give their molecules the best chance of success at later stages, all in 8-12 weeks.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.